Produkty 112811-57-1

CAS 112811-57-1 występuje w naszej ofercie pod nazwami: Gatifloxacin Impurity 5 (3-Desmethyl Gatifloxacin), 3-Desmethyl Gatifloxacin, PD 135042 95%, GATIFLOXACIN RELATED COMPOUND D, 1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, 95%, 95%. Oferty producentów: Chemat Brand, TRC, Ambeed, Sigma-Aldrich, Chemat. Dostępne opakowania: on request, 100mg, 250mg, 1g, 15MG, 1 g, 25 mg, 50 mg.

Gatifloxacin Impurity 5 (3-Desmethyl Gatifloxacin)
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
3-Desmethyl Gatifloxacin
TRC, MedChemExpress
  • opakowanie: 100mg, 1 g, 25 mg, 50 mg
  • Warianty: 6
od 454,37
Zobacz produkt
PD 135042 95%
Ambeed
  • opakowanie: 100mg, 250mg, 1g
  • Warianty: 3
od 481,62
Zobacz produkt
GATIFLOXACIN RELATED COMPOUND D
Sigma-Aldrich
  • opakowanie: 15MG
  • Warianty: 1
od 8512,00
Zobacz produkt
1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, 95%, 95%
Chemat
  • opakowanie: 100mg, 250mg, 1g
  • Warianty: 3
od 386,00
Zobacz produkt
3-Desmethyl Gatifloxacin, 98%
Fluorochem
  • opakowanie: 100mg, 250mg, 1g
  • Warianty: 3
od 700,81
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid (CAS 112811-57-1) to związek chemiczny o wzorze sumarycznym C18H20FN3O4 i masie molowej 361.4 g/mol. Nazwa systematyczna IUPAC: 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid. InChIKey: XJCSNIFKGXSDGN-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC18H20FN3O4
Masa molowa361.4 g/mol
Nazwa IUPAC1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
InChIKeyXJCSNIFKGXSDGN-UHFFFAOYSA-N
SMILESCOC1=C2C(=CC(=C1N3CCNCC3)F)C(=O)C(=CN2C4CC4)C(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3-Desmethyl Gatifloxacin, Desmethyl Gatifloxacin, 8-methoxyciprofloxacin, 3-DesmethylGatifloxacin-d8, Gatifloxacin USP Related Compound D, XJCSNIFKGXSDGN-UHFFFAOYSA-N, Gatifloxacin Impurity D, Gatifloxacin USP IMpurity D, Gatifloxacin USP Impurity D, DESMETHYL GATIFLOXACIN [USP IMPURITY]
Izomery (ten sam wzór sumaryczny)
(2R)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
7-(4-acetylpiperazin-1-yl)-1-ethyl-6-fluoro-4-oxoquinoline-3-carboxylic acid C18H20FN3O4
1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide C18H20FN3O4
7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
6-fluoro-2-methyl-7-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
6-fluoro-2,2-dimethyl-5-(4-methylpiperazin-1-yl)-9-oxo-3-oxa-1-azatricyclo[6.3.1.04,12]dodeca-4(12),5,7,10-tetraene-10-carboxylic acid C18H20FN3O4
(2S)-7-fluoro-2-methyl-10-oxo-6-[4-(trideuterio(113C)methyl)piperazin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
(3S)-7-fluoro-3-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
(2S)-6-fluoro-2-methyl-7-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
(2S)-7-fluoro-2-methyl-6-(2,2,3,3,5,5,6,6-octadeuterio-4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid C18H20FN3O4
2-(2-fluorophenyl)-7-[(2-methylpropan-2-yl)oxycarbonyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-6-carboxylic acid C18H20FN3O4